422 related articles for article (PubMed ID: 5096462)
1. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
[No Abstract] [Full Text] [Related]
2. L-dopa and amantadine hydrochloride in Parkinson's disease.
Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
[No Abstract] [Full Text] [Related]
3. L-dopa for parkinsonism.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1973 Jan; 28(1):86-8. PubMed ID: 4683093
[No Abstract] [Full Text] [Related]
4. Combined treatment of parkinsonism with L-dopa and amantadine.
Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
[No Abstract] [Full Text] [Related]
5. Levodopa and amantadine in the treatment of Parkinsonism.
Critchley E
Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037
[No Abstract] [Full Text] [Related]
6. [Study of L-dopa treatment and its principal side effects in aged subjects].
Antonini F; Baroni A; Bucalossi A; Roveyaz L
Gerontol Clin (Basel); 1972; 14(5):297-309. PubMed ID: 4144357
[No Abstract] [Full Text] [Related]
7. Levodopa and related drugs.
Med Lett Drugs Ther; 1973 Mar; 15(5):21-3. PubMed ID: 4697470
[No Abstract] [Full Text] [Related]
8. Improvement in mono-manual dexterity in parkinsonism when supplementing levodopa with an extracerebral decarboxylase inhibitor, RO 4-4602.
Knutsson E; Mårtensson A
Scand J Rehabil Med; 1974; 6(2):89-93. PubMed ID: 4837060
[No Abstract] [Full Text] [Related]
9. L-dopa therapy in Parkinson's disease.
Lipman IJ
Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138
[No Abstract] [Full Text] [Related]
10. Trial of amantadine in Parkinson's disease.
Campbell AM; Williams MJ
Br J Clin Pract; 1972 Jan; 26(1):19-22. PubMed ID: 4554563
[No Abstract] [Full Text] [Related]
11. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
Sigwald J; Raymondeaud C; Piot C
Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
[No Abstract] [Full Text] [Related]
12. [Management of Parkinson's syndrome using levadopa. Results of a long-term study].
Wälzholz U
Dtsch Med Wochenschr; 1972 Apr; 97(17):686 passim. PubMed ID: 4554502
[No Abstract] [Full Text] [Related]
13. The treatment of parkinsonism with L-Dopa and amantadine.
Green J
J Fla Med Assoc; 1970 Jun; 57(6):28-33. PubMed ID: 5445813
[No Abstract] [Full Text] [Related]
14. [Advances in the treatment of parkinsonism].
Dowzenko A
Neurol Neurochir Pol; 1972; 6(2):275-80. PubMed ID: 4555308
[No Abstract] [Full Text] [Related]
15. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
Schneider E; Fischer PA; Jacobi P
Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456
[No Abstract] [Full Text] [Related]
16. Levodopa in treating Parkinsonism.
O'Doherty DS
Am Fam Physician; 1971 Nov; 4(5):95-9. PubMed ID: 5117507
[No Abstract] [Full Text] [Related]
17. L-dopa and amantadine for Parkinsonism.
Drug Ther Bull; 1970 Aug; 8(17):65-7. PubMed ID: 5480244
[No Abstract] [Full Text] [Related]
18. [6 months of treatment with amantadine and L-Dopa. Comparison in 2 groups of patients with parkinsonism].
Buscaino GA; Campanella G; Zallone E
Minerva Med; 1971 Oct; 62(82):3974-8. PubMed ID: 5125057
[No Abstract] [Full Text] [Related]
19. Amantadine hydrochloride in treatment of Parkinsonism.
Nagaswami S; Nagaswami R
Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
[No Abstract] [Full Text] [Related]
20. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464
[No Abstract] [Full Text] [Related]
[Next] [New Search]